These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24296403)

  • 1. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole.
    Ahad A; Aqil M; Ali A
    Int J Biol Macromol; 2014 Mar; 64():144-9. PubMed ID: 24296403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
    Nanomedicine; 2012 Feb; 8(2):237-49. PubMed ID: 21704600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol
    Ahad A; Al-Saleh AA; Al-Mohizea AM; Al-Jenoobi FI; Raish M; Yassin AEB; Alam MA
    Biomed Pharmacother; 2017 May; 89():177-184. PubMed ID: 28237913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of valsartan: I. Effect of various terpenes.
    Rizwan M; Aqil M; Ahad A; Sultana Y; Ali MM
    Drug Dev Ind Pharm; 2008 Jun; 34(6):618-26. PubMed ID: 18568912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery enhancement of haloperidol from gel formulations by 1,8-cineole.
    Elgorashi AS; Heard CM; Niazy EM; Noureldin OH; Pugh WJ
    J Pharm Pharmacol; 2008 Jun; 60(6):689-92. PubMed ID: 18498703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and development of ethosomal transdermal drug delivery system of valsartan with preclinical assessment in Wistar albino rats.
    Bhosale SS; Avachat AM
    J Liposome Res; 2013 Jun; 23(2):119-25. PubMed ID: 23324030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano vesicular lipid carriers of angiotensin II receptor blocker: Anti-hypertensive and skin toxicity study in focus.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):1002-7. PubMed ID: 25707444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ameliorated longevity and pharmacokinetics of valsartan released from a gel system of ultradeformable vesicles.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1457-63. PubMed ID: 25953248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic enhancement of papaverine transdermal gel for erectile dysfunction.
    Wen MM; El-Kamel AH; Khalil SA
    Drug Dev Ind Pharm; 2012 Aug; 38(8):912-22. PubMed ID: 22080854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes.
    Prasad PS; Imam SS; Aqil M; Sultana Y; Ali A
    Drug Deliv; 2016; 23(3):1057-66. PubMed ID: 25033041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study.
    Khan MA; Pandit J; Sultana Y; Sultana S; Ali A; Aqil M; Chauhan M
    Drug Deliv; 2015; 22(6):795-802. PubMed ID: 24735246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion.
    Park YJ; Lee HK; Im YB; Lee W; Han HK
    Arch Pharm Res; 2010 Aug; 33(8):1235-40. PubMed ID: 20803127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
    Drug Dev Ind Pharm; 2011 May; 37(5):583-96. PubMed ID: 21469947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
    Kometani M; Hayashi N; Yamamoto S; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.